SIU Scientific Programme 2018


Thursday, October 04

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0715-1615

SYMP-01: World Urologic Oncology Federation    

Room: 5F Baekdu D
Chair: Laurence Klotz, Canada

To view a PDF of the WUOF programme, please click here.

0715-0745    

Meet and Greet International Colleagues (coffee and refreshments served)

0745-0750    

Framing of Theme

Laurence Klotz, Canada
0750-0910    

SESSION I: Prostate Cancer Screening and Prevention

Moderators
Laurence Klotz, Canada
Ji Youl Lee, South Korea
0755-0802    

Prostate Cancer Screening: European Perspective

Franz Recker, Switzerland
0805-0812    

Prostate Cancer Screening: American Perspective

Matthew Cooperberg, United States
0815-0822    

Prostate Cancer Screening: Japanese Perspective

Shin Egawa, Japan
0825-0832    

Prostate Cancer Screening: Latin American Perspective

Arturo Mendoza-Valdes, Mexico
0835-0842    

PSA Cutpoint Should be 1.5

E. David Crawford, United States
0845-0852    

FSH and Prostate Cancer

Jehonathan Pinthus, Canada
0900-0910    

Discussion

0910-1040    

SESSION II: Prostate Cancer Management Options

Moderators
Yves Fradet, Canada
Sung Kyu Hong, South Korea
   

CASE & DEBATE – MANAGEMENT OF GRADE GROUP 2 PROSTATE CANCER

0915-0925    

Surveillance

Sung Kyu Hong, South Korea
0925-0935    

Focal Therapy

Rafael Sanchez-Salas, Canada
0935-0945    

Radical Therapy

Neil Fleshner, Canada
0945-0955    

Discussion

0955-1007    

Can Ultrasound Imaging Replace MRI?

Peter Hammerer, Germany
1007-1019    

Can MRI Replace Prostate Biopsy?

Guillaume Ploussard, France
1019-1029    

Integrating Imaging and Biomarkers in Prostate Cancer Diagnosis

Derya Tilki, Germany
1029-1040    

Discussion

1040-1135    

SESSION III: Kidney Cancer

Moderators
Alessandro Volpe, Italy
Ofer Yossepowitch, Israel
1042-1054    

Challenges in Cystic Renal Tumours

Makarand Khochikar, India
1054-1106    

Angiogenesis Markers in RCC

Hanjong Ahn, South Korea
1106-1118    

Where to Draw the Line Between Radical and Partial Nephrectomy?

Peter Mulders, The Netherlands
1118-1130    

Adjuvent Therapy in RCC Post Nephrectomy

Robert Flanigan, United States
1130-1135    

Discussion

1135-1200    

Working Lunch (Complimentary Meal to All Seated Participants Attending Session Four Working Lunch)

1200-1330    

SESSION IV: Town Hall—Emerging Diagnostic Biomarkers in Prostate Cancer

Moderator: Laurence Klotz, Canada
1200-1210    

Introduction: The Unmet Need for Liquid Biopsy in the Diagnostic Pathway

Matthew Cooperberg, United States
1210-1239    

BENCH TO BEDSIDE: WHAT IS THE LATEST DATA ON EMERGING BIOMARKERS?

1210-1220    

Urinary Micro RNAs and SNOs as a Prostate Cancer Biomarker Platform

Martin Tenniswood, United States
1220-1230    

Emerging Biomarkers in Prostate Cancer

Jack Schalken, The Netherlands
1230-1240    

Radiogenomics

Robert Reiter, United States
1240-1300    

PANELISTS: BIOMARKERS IN PROSTATE CANCER: Current Role of Molecular Biomarkers in the Management of Prostate Cancer: Which Ones and Why?

1240-1245    

Panelist 1

Shin Egawa, Japan
1245-1250    

Panelist 2

Marc Dall'Era, United States
1250-1255    

Panelist 3

Robert Reiter, United States
1255-1300    

Panelist 4

Derya Tilki, Germany
1300-1330    

Open Discussion

1330-1420    

SESSION V: Prostate Cancer Treatment Options

Moderators
Damien Bolton, Australia
John Davis, United States
1332-1344    

Improving the Outcome of Men on Active Surveillance

Marc Dall'Era, United States
1344-1356    

RP in Men Over Age 75: Is it Folly?

Shomik Sengupta, Australia
1356-1408    

Advances in MR-U/S Fusion Guided

Ardeshir Rastinehad, United States
1408-1418    

Discussion

1420-1520    

SESSION VI: Urothelial Cancer

Moderators
Michael Leveridge, Canada
Robert Siemens, Canada
1422-1434    

Liquid Biopsy for Bladder Cancer Prognosis

Peter Black, Canada
1434-1446    

Impact of Urinary Marker Testing in Bladder Cancer

Badrinath Konety, United States
1446-1458    

Clinical Implications of Mutational Profiling of Invasive Bladder Cancer

Seth Lerner, United States
1458-1510    

Should Variant Histology Change Management of Bladder Cancer?

Ashish M. Kamat, United States
1510-1520    

Discussion

1520-1615    

SESSION VII: Advanced Prostate Cancer

Moderator: Marcelo Luiz Bendhack, Brazil
1522-1534    

Medical Tourism in Urologic Oncology: Korean Perspective

Ji Youl Lee, South Korea
1534-1546    

PSMA in the Management of Patients with Biochemical Failure

Shrawan Kumar Singh, India
1546-1558    

Chemotherapy and Radium for CRP - Role in the Era of ARTs

Peter Black, Canada
1538-1615    

How to Reduce Errors in Scientific Research

Laurence Klotz, Canada

0730-1430

LS: SIU eGrand Rounds on Stone Disease and BPO    

Room: 5F Baekdu A+B
Chair: Jean de la Rosette, Türkiye

0800-1630

SYMP-05: Korean Urological Association Symposium (in Korean)  

Room: 4F Baekje 2/3/4
Chair: Cheol Kwak, South Korea
0800-0805    

Welcome Remarks and Introduction

Jun Cheon, South Korea
0805-0920    

SESSION I: Bladder Cancer

Moderators
Jin Seon Cho, South Korea
Cheol Kwak, South Korea
0805-0820    

Gut Microbiome and Immunotherapy

Seok Joong Yun, South Korea
0820-0835    

Significance of Histologic Variants

Ja Hyeon Ku, South Korea
0835-0850    

Robotic-Assisted Radical Cystectomy in Korea

Seok Ho Kang, South Korea
0850-0905    

Immune Checkpoint Inhibitors for Bladder Cancer in Korea

Ho Kyung Seo, South Korea
0905-0920    

Panel Discussion

Discussants
Beom Sik Hong, South Korea
Byong Chang Jeong, South Korea
Moon Ki Jo, South Korea
0920-1035    

SESSION II: Minimally Invasive Surgery for Renal Cell Carcinoma

Moderators
Youn Soo Jeon, South Korea
Tae Gyun Kwon, South Korea
0920-0935    

Laparoscopic IVC Thrombectomy

Sung-Hoo Hong, South Korea
0935-0950    

My Surgical Tip of Robot-Assisted Partial Nephrectomy

Cheryn Song, South Korea
0950-1005    

The Role of Robotic/Laparoscopic Surgery in the Management of Cystic RCC

Jae Young Park, South Korea
1005-1020    

da Vinci Xi Single Port Partial Nephrectomy

Woong Kyu Han, South Korea
1020-1035    

Panel Discussion

Discussants
Jinsoo Chung, South Korea
Seong Il Seo, South Korea
1035-1150    

SESSION III: Prostate Cancer

Moderators
Sung Kyu Hong, South Korea
Ji Youl Lee, South Korea
1035-1050    

Prostate Cancer: Does Race Matter?

In Gab Jeong, South Korea
1050-1105    

How Does PET Scan Help in the Management of Prostate Cancer?

Nathan Lawrentschuk, Australia
1105-1135    

Are We Ready for Focal Therapy in Prostate Cancer?

   

Yes

Hwang Gyun Jeon, South Korea
   

No

U-Syn Ha, South Korea
1135-1150    

Panel Discussion

Jae Young Joung, South Korea
Taek Won Kang, South Korea
Yong Hwii Ko, South Korea
1150-1240  

Break

1240-1355    

SESSION IV: Aging Lower Urinary Tract (In English)

Moderators
Dae Kyung Kim, South Korea
Claus Roehrborn, United States
1240-1255    

Basic Physiology of Aging Lower Urinary Tract

Yun Seob Song, South Korea
1255-1310    

Special Considerations in the Management of Frail Elderly Population

Su-Jin Kim, South Korea
1310-1325    

Management of Bladder Outlet Obstruction in Underactive Bladder

Eun Sang Yoo, South Korea
1325-1340    

Timing of Intervention for LUTS/BPO/BPE and BPH: Do We Have it Right?

Claus Roehrborn, United States
1340-1355    

Panel Discussion

Discussants
Su-Jin Kim, South Korea
Yun Seob Song, South Korea
Eun Sang Yoo, South Korea
1355-1510    

SESSION V: Erectile Dysfunction after Radical Prostatectomy

Moderators
Du Geon Moon, South Korea
Dae Yul Yang, South Korea
1355-1410    

Update on Basic/Translational Research for ED after Radical Prostatectomy

Ji-Kan Ryu, South Korea
1410-1425    

Current Status of Clinical Role of Penile Rehabilitation

Won Ki Lee, South Korea
1425-1440    

Options after Initial PDE5 Inhibitor Failure

Min Chul Cho, South Korea
1440-1455    

Surgical Tips for Penile Prosthesis Implantation after Radical Prostatectomy

Hong Seok Shin, South Korea
1455-1510    

Panel Discussion with Clinical Case

Panelists
Soo-Woong Kim, South Korea
Ki Hak Moon, South Korea

Presenter: Jun Nyung Lee, South Korea
1510-1625    

SESSION VI: Practice Issues of Pediatric Diseases in Adolescent and Adult Patients

Moderators
Chang Hee Han, South Korea
Sang Don Lee, South Korea
1510-1525    

Vesicoureteral Reflux

Sang Hoon Song, 대한민국
1525-1540    

Hydronephrosis (Ureteropelvic Junction Obstruction)

Young Jae Im, South Korea
1540-1555    

Nocturnal Enuresis

Jae Min Chung, South Korea
1555-1610    

Hypospadias

Sang Woon Kim, South Korea
1610-1625    

Panel Discussion

Discussants
Minki Baek, South Korea
Jung Yoon Kang, South Korea
Jun Mo Kim, South Korea
Kwanjin Park, South Korea
1625-1630    

Closing Remarks

Jun Cheon, South Korea

0800-1630

SYMP-02: Urology in Asia  

Room: 5F Baekdu C
Co-Chairs: Shin Egawa, Japan / Sang Won Han, South Korea
0800-0805    

Welcome Remarks and Introduction

Allen W. Chiu, Taiwan
Sang Won Han, South Korea
0805-0920    

SESSION I: Functional Urology in Asia

Moderators
Jun Hyuk Hong, South Korea
Jang Hwan Kim, South Korea
0805-0820    

New Technology for LUTS Research

Tack Lee, South Korea
0820-0835    

Update of Clinical Insights on Storage Symptoms: How to Increase Adherence and Outcomes?

Jose Buenaventura Reyes, Philippines
0835-0850    

Mixed Urinary Incontinence: What First?

Jeremy Yuen-Chun Teoh, Hong Kong
0850-0905    

Controversy on Incontinence in Males: Pelvic Floor Training, Medication, and Surgery

Hana Yoon, South Korea
0905-0920    

Panel Discussion

Discussants
Jose Buenaventura Reyes, Philippines
Tack Lee, South Korea
Jeremy Yuen-Chun Teoh, Hong Kong
0920-1035    

SESSION II: Endourology

Moderators
Tae Hyo Kim, South Korea
Seiji Naito, Japan
0920-0935    

Role of Flexible Ureteroscope and PCNL in Patients with Anomalous Upper Urinary Tract

Mahesh R. Desai, India
0935-0950    

Current Trend of Managing Pediatric Urinary Stones/New Technologies in RIRS

Deok Hyun Han, South Korea
0950-1005    

Super-Mini-PCNL

Guohua Zeng, China
1005-1020    

How to Minimize Complication while Maximizing Outcomes of RIRS

Bannakij Lojanapiwat, Thailand
1020-1035    

Panel Discussion (Case Presentations)

Discussants
Chaidir Mochtar, Indonesia
Jeremy Yuen-Chun Teoh, Hong Kong
Young Eun Yoon, South Korea
1035-1150    

SESSION III: Infection

Moderators
Yong Hyun Cho, South Korea
Tetsuro Matsumoto, Japan
1035-1050    

Global Prevalence of Urogenital Tract Infections: Emerging Threats

Dong Hoon Lim, South Korea
1050-1105    

Prevention of Perioperative Infections in the Urological Field

Shingo Yamamoto, Japan
1105-1120    

Mycoplasma Genitalium: An Important Emerging STI

Seung-Ju Lee, South Korea
1120-1135    

Treatment Strategies for Genital Lesions of STI

Shrawan Kumar Singh, India
1135-1150    

Panel Discussion

Discussants
Seung-Ju Lee, South Korea
Dong Hoon Lim, South Korea
Shrawan Kumar Singh, India
Shingo Yamamoto, Japan
1150-1250  

Break

1250-1405    

SESSION IV: New Technologies in the Management of Prostate Cancer

Moderators
Shin Egawa, Japan
Gyung Tak Mario Sung, South Korea
1250-1305    

Advanced Prostate Cancer Registry from 8 Asian Countries

Yeong-Shiau Pu, Taiwan
1305-1320    

HIFU for Prostate Cancer: Current Status and Outcomes

Sunao Shoji, Japan
1320-1335    

Development of New Robotics Platforms for Prostate Cancer

Koon Ho Rha, South Korea
1335-1350    

Emerging Technology in Prostate Cancer Radiation Therapy

Young Seok Kim, South Korea
1350-1405    

Panel Discussion

Discussants
Sang Hyeon Cheon, South Korea
Sung Kyu Hong, South Korea
Jason Letran, Philippines
1405-1520    

SESSION V: Kidney Cancer

Moderators
Masatoshi Eto, Japan
Seong Il Seo, South Korea
1405-1420    

Therapeutic Vaccine for Renal Cell Carcinoma

Selvalingam Sothilingam, Malaysia
1420-1435    

Current Status and Future Perspectives regarding Biomarkers for Renal Cell Carcinoma

Masatoshi Eto, Japan
1435-1450    

Longitudinal Changes in Renal Function after Radical Nephrectomy and Risk Factors for Postoperative Severe Renal Impairment

Jeong-Hyun Kim, South Korea
1450-1505    

Percutaneous Therapies in Small Renal Mass

1505-1520    

Panel Discussion

Discussants
Keong Tatt Foo, Singapore
Robin Joshi, Nepal
Jeong-Hyun Kim, South Korea
Rohan Malek, Malaysia
1520-1635    

SESSION VI: Emerging Treatment Modalities in Long Standing Disease: Peyronie's Disease

Moderators
Hyun Jun Park, South Korea
Rainy Umbas, Indonesia
1520-1535    

Extracorporeal Shock Wave Therapy: Pros

Min Gu Park, South Korea
1535-1550    

Extracorporeal Shock Wave Therapy: Cons

Hong-Chiang Chang, 台灣
1550-1605    

Collagenase Clostridium Histolyticum: Pros

1605-1620    

Collagenase Clostridium Histolyticum: Cons

Mai Ba Tien Dung, Vietnam
1620-1630    

Panel Discussion

Discussants
Hong-Chiang Chang, 台灣
Mai Ba Tien Dung, Vietnam
Min Gu Park, South Korea
Mohammad Ali Sadighi Gilani, Iran

0800-1200

SYMP-04: 7th Symposium on Affordable New Technologies in Urology (SANTU) & 2nd Best Affordable New Technologies in Urology Contest (BANTUC)  

Room: 4F Baekje 6
Chair: Mohammed Lezrek, Morocco
Co-Chair: Christian Bach, Germany
Honorary Chair: Daniel Yachia, Israel
0700-0845    

Poster Viewing

0845-0855    

Opening SANTU 7

Mohammed Lezrek, Morocco
0855-1110    

SANTU Lectures

0855-0910    

Using Modern Technology to Promote Surgical Care in Developing Countries

Christian Bach, Germany
0910-0920    

ePoster Presentations

   

Cost-Utility Analysis of Upfront Pharmacotherapy Compared to an Upfront Surgical Intervention for Patients with Benign Prostate Hyperplasia

Dean Elterman, Canada
   

Cystoscopic Stent Removal Using Smartphone

Shanky Singh, India
   

A Novel Mobile Acoustic Uroflowmetry: Comparison of Uroflowmetry and Mobile Acoustic Uroflowmetry

Young Ju Lee, South Korea
0920-0935    

How to Set Up a Sustainable Endourology Programme in a Middle Income Country

Hichem Kouicem, Algeria
0935-0945    

ePoster Presentations

   

The Use of Unconventional Instruments in Emergency Room of Urology

Petrisor Aurelian Geavlete, Romania
   

Small Steps, Hand-in-Hand, Leaving No One Behind—One Possible Solution to the Growing Disparity in Global Surgery: The West African Experience

Emmanuel Abara, Canada
   

To Assess the Efficacy of Lidocaine Jelly in Preventing Stone Fragment Retropulsion During Ureteroscopic Lithotripsy for Ureteral Stones: A Systemic Review and Meta-Analysis

Kunpeng Shu, China
0945-1000    

Re-Use and Re-Cycle: Saving Resources in Developing Countries

Daniel Yachia, Israel
1000-1010    

ePoster Presentations

   

Vessel Sparing Anastomotic Urethroplasty for Pelvic Fracture Urethral Distraction Defects

Pankaj Joshi, India
   

Success of TURP in Urodynamically Proven Hypo Contractile Bladders

Gopesh Bishnoi, India
   

Percutaneous Tract Dilation Training on a Pumpkin

Mohammed Lezrek, Morocco
1010-1025    

The Economic Benefits of Teaching Urology in Low- and Middle-Income Countries

Kurt McCammon, United States
1025-1035    

ePoster Presentations

   

BTSK Model of Teaching PCNL to Trainee

Pratikkumar Shah, India
   

Trichosanthes Kirilowii Fruits as a Therapeutic Agent for Urothelial Carcinoma of the Bladder

Ning Jiang, China
   

Platelet Rich Plasma in Erectile Dysfunction

Raouf Salti, France
1035-1050    

Think Out of the Box—How to Find New Solutions for Old Problems in Endourology

Mohammed Lezrek, Morocco
1050-1150    

2nd Best Affordable New Technologies in Urology Contest (BANTUC)

1050-1055    

Presentation of the 2nd Best Affordable New Technologies in Urology Contest

Daniel Yachia, Israel
1055-1145    

Presentation of Projects by Finalists

   

Ultra-Low-Cost Wireless Endoscopic Camera

John Lazarus, South Africa
   

Laparoscopic Ureteric Stent Guider (LUSG)

Mohammed Al-Ameedee, Iraq
   

14G Angiocath as Needle Guide in Freehand

Ka Lun Lo, China
   

Cost Effective “Three in one” Chicken Carcass Model for Training in Laparoscopic Urologic Procedures

Arvind Ganpule, India
   

A Novel Disposable and Cost Effective (DICE) Nephroscope for Affordable PCNL

Regi Septian, Indonesia
   

Infant Feeding Tube as Rectal Bulb Catheter for Abdominal Pressure Monitoring

Amit Jain, India
   

Light When There Is No Light

Ganesh Prasad Sankarapandian, India
   

Question and Answer

1145-1150    

Announcement of results and award distributions for BANTUC

Daniel Yachia, Israel
1150-1155    

Award distributions for the Best Moderated Poster, Best Un-moderated Poster and Best Video presentations

Mohammed Lezrek, Morocco
   

Closing SANTU-7

Mohammed Lezrek, Morocco
   

Invitation to SANTU-8 2019 and 3rd Best Affordable New Technologies in Urology Contest

Daniel Yachia, Israel

0800-1100

INN: SIU Innovators' Symposium  

Room: 5F Goguryeo 1/2/3
Co-Chairs: Shusuke Akamatsu, Japan / M. Hadi Radfar, Iran
Social Media Moderator: Amanda Chung, Australia

At the end of this session, the learner will:

  • Summarize the future application of virtual and augmented reality in urologic oncology.
  • Compare pros and cons of image-guided procedures versus traditional standard procedures
  • Discuss early career challenges for a young urologist
0800-0900    

Part 1: Virtual and Augmented Reality in Urologic Surgery

Moderators
Peter Black, Canada
M. Hadi Radfar, Iran
0800-0807    

Navigation System for Robotic Assisted Partial Nephrectomy

Atsuro Sawada, Japan
0807-0814    

Patient-Specific 3D Print Kidney Models for Robotic Assisted Partial Nephrectomy

Fumiya Hongo, Japan
0814-0821    

A Real-Time Support System for Robotic-assisted Radical Prostatectomy using MRI-based Virtual Reality Models

Sherif Mehralivand, United States
0821-0828    

Indigenous Innovations: Making PCNL Simulation Affordable

0828-0838    

Future of Robotic Surgery in Urology

Koon Ho Rha, South Korea
0838-0900    

Panel Discussion

0900-1000    

Part 2: How has Image-Guided Urology Changed Practice?

Moderators
Shusuke Akamatsu, Japan
Nathan Lawrentschuk, Australia
   

Debate—Small Renal Mass

   

Partial Nephrectomy

Henry Ho, Singapore
   

Ablative Therapy

Homayoun Zargar, Australia
   

Debate: Prostate Cancer Diagnosis

   

TRUS Biopsy

Andrés Hernández-Porras, Mexico
   

MRI-TRUS Fusion Biopsy

Guillaume Ploussard, France
   

Debate: Management of BPH

   

Office-Based Intervention (Urolift/iTEND/…)

Dean Elterman, Canada
   

OR (TURP, Green Light)

Amanda Chung, Australia
1000-1100    

Part 3: Mastering Early Career Challenges

Moderator: Dean Elterman, Canada
1000-1020    

Starting your career in…

   

North America

   

Europe

Siska van Bruwaene, Belgium
   

East Asia

Sung Yong Cho, South Korea
   

South Asia

   

Discussion

1035-1042    

Taking Control of Your Online Footprint

Michael Leveridge, Canada
1042-1049    

Research: International Collaborations for Young Urologists

Todd Manning, Australia
1049-1056    

Looking Back and Facing Forward: Building an Academic Career

Peter Black, Canada

0800-1100

SYMP-06: SIU-ICUD Consultation on Congenital Lifelong Urology  

Room: 3F Shilla 4
Co-Chairs: Dan Wood, United States / Hadley Wood, United States
Social Media Moderator: Imogen Patterson, Australia

At the end of this session, the learner will:

  • Describe basic tenets of the transition process from pediatric to adult urologic care in patients with congenital urological diseases, including when and how to initiate the process, the role of multiple disciplines, and the key stakeholders
  • Describe the challenges surrounding urological care in adolescence, including physiologic and biologic changes that impact care and how to manage these issues through transition to adult care
  • Understand and describe approach to genital revision surgery within the context of periadolescence and young adulthood, including fertility (male and female) and pregnancy (for females) consultation
  • Understand triggers and implement surveillance in adult life for patients with congenital neuropathic bladder, including cancer surv
  • Interpret renal function through aging using creatinine-based and non-creatinine based techniques, when and how to involve nephrologic consultation, and considerations for kidney transplant
  • Describe and implement routine age-related urologic surveillance in individuals with congenitally abnormal urologic systems, including treatments for BPH, prostate cancer, hypogonadism and pelvic prolapse
0800-0830    

The Basics of Transition

Rosalia Misseri, United States
0830-0900    

Challenges to the Paradigms in Paediatric Practice Based on the Long-term View

John Wiener, United States
0900-0930    

Genital/Urethra – Sexual Function and Fertility

Gunter De Win, Belgium and UK
0930-1000    

Complications in Adulthood for Patients with Paediatric Reconstruction

Stephanie Kielb, United States
1000-1030    

Upper Tract Considerations

Elizabeth Yerkes, United States
1030-1100    

Age-related Urological Problems in the Complex Urological Patient

Claire Taylor, United Kingdom

0800-1100

SYMP-03: World Chinese Urology (in Mandarin)  

Room: 3F Shilla 1/2/3
Co-Chairs: Yinghao Sun, China / Li-Ping Xie, People's Republic of China
0800-0806    

Welcome and Introduction

Yinghao Sun, China
0806-0919    

Urological Oncology

Liqun Zhou, China
Moderator: Yinghao Sun, China
0806-0815    

Development History of Infection and Inflammation Group of CUA

Junhua Zheng, China
0815-0824    

Selection of Pelvic and Postperitoneal Lymph Node Dissection to Treat Metastatic Lymph Nodes after Radical Prostatectomy

Xin Gao, China
0824-0833    

The Safety Consensus of Prostate Cancer Endocrine Therapy

Haifeng Wang, China
0833-0842    

Better Castration Level, More Survival Benefits

Qian Zhang, China
0842-0851    

Changing Landscape In the Management of Metastatic Castration Sensitive Prostate Cancer

Liqun Zhou, China
0851-0900    

Prostate Cancer Treatment in China: Changing Paradigm and Current Consensus

Yao Zhu, China
0900-0909    

The Clinical Application and Progress of GnRH Antagonist in Prostate Cancer Hormonal Treatment

Xin Gao, China
0909-0918    

Cognitive Targeted Prostate Biopsy

Haifeng Wang, China
0918-0954    

Urolithiasis

Moderators
Jiwen Cheng, China
Guohua Zeng, China
0918-0927    

Multiple Tract PCNL for Complex Renal Stones

Guohua Zeng, China
0927-0936    

The Advantages of Moses Technology in SMP

Guohua Zeng, China
0936-0945    

What We Have Done: The Progress of Upper Urinary Tract Calculi Management in China

Shaogang Wang, China
0945-0954    

Sun’s Tip-flexible Semi-rigid Ureteroscope: State of the Art

Rui Chen, China
0954-1057    

Minimally Invasive Urology

Moderator: Nianzeng Xing, China
0954-1003    

Technical Innovations of Changhai Hospital in the Treatment of Renal Cell Carcinoma

Chao Zhang, China
1003-1012    

1500 Cases of Robotic Urological Surgery: A Single Center Experience

Dong Wang, China
1012-1021    

The Future Development Trends of Endoscop

Nianzeng Xing, China
1021-1030    

Evolution and Development of Laparoscopic Equipment

Junhua Zheng, China
1030-1039    

Bipolar Plasmakinetic Transurethral Endoscopic Enucleation of BPH over 200g: With 24 Cases

Zhihui Zou, China
1039-1048    

BPH Management Strategy with 180W Greenlight Laser

Shaogang Wang, China
1048-1057    

Experience on Treatment of Pelvic Organ Prolapse and Stress Incontinence with Transperineal Mesh

Yaoguang Zhang, China

1100-1300

SYMP-07: World Journal of Urology Symposium  

Room: 3F Shilla 1/2/3
Co-Chairs: Rajeev Kumar, India / Guillaume Ploussard, France
1100-1130    

The Structure of a Paper

Guillaume Ploussard, France
1130-1200    

Why do My Papers Get Rejected?

Rajeev Kumar, India
1200-1220    

What Does an Editor Want From Reviewers?

Joseph A. Smith, United States
1220-1240    

Identifying Pseudo-Journals

Kwangsung Park, South Korea
1240-1300    

The Role of Mid-Level Journals

Yoshihiko Tomita, Japan

1100-1600

KUA-MP: KUA Moderated ePoster Session (English)  

Room: 5F Goguryeo 1/2/3

To view a list of scheduled presentations for this session, please click here

1100-1205    

KUA-01: Prostate Cancer

Moderators
Hong Koo Ha, South Korea
Jae Young Park, South Korea
1205-1305    

KUA-02: Functional Urology and Investigational Research

Moderator: Jong Bo Choi, South Korea
1305-1425    

KUA-03: Andrology, Infertility, Endourology and Pediatric Urology

Moderators
Hyung Joon Kim, South Korea
Hyun Jun Park, South Korea
1425-1540    

KUA-04: Prostate and Other Genitourinary Cancers

Moderators
Ja Hyeon Ku, South Korea
Dongdeuk Kwon, South Korea

1200-1300

SYMP-08: Innovations in MIS Technology  

Room: 3F Shilla 4
Chair: Gyung Tak Mario Sung, South Korea
1200-1220    

Application of 8K Endoscope and AI Navigation in Surgery

Makoto Hashizume, Japan
1220-1240    

Treating Prostate Cancer Non-Invasively

Li-Ping Xie, People's Republic of China
1240-1300    

MIS Technology in BPH Treatment

Henry Ho, Singapore

1200-1500

SYMP-09: Urology in the Middle East  

Room: 4F Baekje 6
1200-1230    

Overactive Bladder

1200-1215    

Sacral Neuromodulation

1215-1230    

Botox Injection

Ajay Singla, United States
1230-1300    

Varicocelectomy in Non-obstructive Azoospermia

1230-1245    

Yes

Mohammad Ali Sadighi Gilani, Iran
1245-1300    

No

Sidney Glina, Brazil
1300-1330    

Peyronie’s Disease Management

1300-1315    

Surgical Management

Joel Gelman, United States
1315-1330    

Non-Surgical Management

Mohammad Ali Zargar, Iran
1330-1400    

Prenatal Hydronephrosis

1330-1345    

Obstructive

John Wiener, United States
1345-1400    

Non-Obstructive

Gholamreza Pourmand, Iran
1400-1430    

Adrenal Mass

1400-1415    

Preoperative Evaluation

Mallikarjuna Chiruvella, India
1415-1430    

Surgical Management

M. Hadi Radfar, Iran
1430-1500    

Ureteropelvic Junction Obstruction

1430-1445    

Laparoscopic:

1445-1500    

Robotic

Mahesh R. Desai, India

1330-1500

SYMP-10: Pan African Urological Surgeons' Association Symposium  

Room: 3F Shilla 4
Co-Chairs: Serigne Magueye Gueye, Senegal / Mohamed Jalloh, Senegal
1330-1430    

SESSION I: On the Clinical Frontier

Moderators
Serigne Magueye Gueye, Senegal
Mobile Kampanga, Democratic Republic of Congo
1330-1340    

Quinolone Resistance among Patients Undergoing Urogenital Stone Treatment in Steve Biko Academic Hospital

Evelyn Mmapula Moshokoa, South Africa
1340-1350    

A Case for House: Pediatric Ureteric Stricture Disease

Lisa Kaestner, South Africa
1350-1400    

Challenges in the Management of Penile Cancer in Resource Limited Environment

Allen Chiura, Zimbabwe
1400-1410    

Prostatic Vaporization TURIS - One Day Surgery: African Experience (About 530 Cases)

Redouane Rabii, Morocco
1410-1420    

A Review of Bladder Cancer in Africa: A Different Disease with a Distinct Presentation and Management

1420-1430    

Survival from Metastatic Prostate Cancer in DRC

Punga Maole, Democratic Republic of Congo
1430-1500    

SESSION II: Strategies to advance Urology in Africa

Moderator: Alex Danso, Zimbabwe
1430-1440    

Minimally Invasive Surgery in Africa: Evidence-Based Practice

Cyril Kamadjou, Cameroon
1440-1450    

Strategic Plan to Eliminate Obstetric Fistula in Africa

Serigne Magueye Gueye, Senegal
1450-1500    

Simulation as Endourology Training Tool in Africa?

Mohamed Jalloh, Senegal

1330-1630

SYMP-11: European Association of Urology Symposium  

Room: 3F Shilla 1/2/3
Chair: Manfred Wirth, Germany
1330-1400    

Molecular Substaging of Urothelial Cancer: The Future

Arnulf Stenzl, Germany
1400-1430    

The Role of miRNA in Oncogenesis and Progression of Prostate Cancer

Manfred Wirth, Germany
1430-1500    

Management of the Underactive Bladder: A Contemporary Update

1500-1530    

Treatment of Localized Prostate Cancer—When: Active Surveillance, Focal Therapy, Radical Prostatectomy or Radiotherapy

Manfred Wirth, Germany
1530-1600    

Pelvic Anatomy for Minimally and Open Surgery: Better Functional Results after Cystectomy and Prostatectomy

Arnulf Stenzl, Germany
1600-1630    

Contemporary Management of Stress Urinary Incontinence in the Female: Synthetic Slings and Beyond?

1500-1630

SYMP-12: Joint Kenya Association of Urological Surgeons and South African Urological Association Symposium  

Room: 3F Shilla 4
Co-Chairs: Shingai Mutambirwa, South Africa / Saeed R. Samnakay, Kenya
   

Squamous Cell Carcinoma of the Urethra: Management Dilemma

Willis Oyieko, Kenya
   

Managing Ureteric Injuries During Ureteroscopy

   

TRUS Guided Prostate Biopsies: Kenyan Experience

SNK Waweru, Kenya
   

Brachytherapy for Early Prostate Cancer in Kenya

P M-Ngugi, Kenya
   

Occupation Bicycle-Riding as a Cause of ED in East Africa

Edward Mugalo, Kenya
   

Dilemma of Managing Undescended Testis in Puberty and Post-Puberty Age-Groups in Kenya

M Omar, Kenya
   

Outcomes of Panurethral Stricture Management at Kenyatta National Hospital, Nairobi

Willy Otele, Kenya
   

An Online Survey on the Practice of Simple Prostatectomy for BPO in Kenya

Patrick Mburugu, Kenya
   

Epidemiology of Stones in Developing Countries

Ismail Khalaf, Egypt
   

Challenges in South African Stone Management

Lisa Kaestner, South Africa
   

Ultra-Low Cost Wireless Endoscope Camera

John Lazarus, South Africa

Friday, October 05

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0730-0830

MC01: Master Class 1—How to Manage Recurrent Non-Muscle Invasive Bladder Cancer  

Room: 4F Baekje 2/3/4
Co-Chairs: Maurizio Brausi, Italy / Thomas Guzzo, United States

At the end of this session, the learner will:

  • Understand optimal transurethral resection techniques for bladder cancer and new technologies to enhance the efficacy and safety of TUR such as blue light cystoscopy
  • Understand the appropriate definition of BCG unresponsive bladder cancer and subsequent treatment options for this subset of patients
  • Understand the indications for early cystectomy in the non-muscle invasive bladder cancer patient
0730-0745    

Transurethral Resection (TUR) of Bladder Tumors in 2018: Did Urologists Improve It?

Trinity Bivalacqua, United States
0745-0750    

Discussion

0750-0805    

Optimal Intravesical Therapy

Maurizio Brausi, Italy
0805-0810    

Discussion

0810-0825    

Early Cystectomy for High-Risk NMIBC: Is It Appropriate?

Seth Lerner, United States
0825-0830    

Discussion

0730-0830

MC02: Master Class 2—Surgical Guidelines and Techniques for Kidney Stones  

Room: 3F Shilla 4
Co-Chair: Mahesh R. Desai, India

At the end of this session, the learner will:

  • Be familiar with different standard and new techniques of PCNL.
  • Be able to recognize the complications of PCNL (complications of patient positioning, Access to the kidney and bleeding after PCNL)
  • Know indications and technique of Laparoscopic pyelolithotomy and nephrolithotomy.
  • Be able to diagnose complications of laparoscopic stone management and their management.
  • Know how to dilate ureter and to place ureteral sheath in the ureter safely.
  • Know the indications of transureteral management of renal pelvic and calcyeal stone (RIRS)
  • Be familiar with how to use proper laser to disintegrate the stone.
0730-0750    

PCNL (Standard, Mini, Micro): Pursuit of Excellence in Management of Staghorn Calculus

Mahesh R. Desai, India
0750-0810    

Laparoscopic Management in Stone Disease

0810-0830    

RIRS: An Update

Emrah Yürük, Turkey

0730-0830

MC03: Master Class 3—How to Achieve Best Quality MR/US Fusion Prostate Biopsy  

Room: 5F Goguryeo 1
Co-Chairs: Jeremy Grummet, Australia / Ardeshir Rastinehad, United States

At the end of this session, the learner will:

  • Understand the basics of MR imaging of the prostate
  • Assess and select patients for MR US fusion guided biopsy
  • Understand of how MR US Fusion guided biopsy technology works and how it is used to perform targeted biopsies.
0730-0745    

Reading Multiparametric Prostate MRI and Reporting Using PI-RADS v2

Byung Kwan Park, South Korea
0745-0800    

Patient Selection and Preparation for MR/US Fusion Prostate Biopsy

Manish Patel, Australia
0800-0815    

Technique for MR/US Fusion Prostate Biopsy

Ardeshir Rastinehad, United States
0815-0830    

Discussion

Discussants
Jeremy Grummet, Australia
Byung Kwan Park, South Korea
Ardeshir Rastinehad, United States

0830-1110

PL01: Plenary 1    

Room: 5F Baekdu A+B
Honorary Chairs: Gopal Badlani, United States / Badrinath Konety, United States / Rajeev Kumar, India
Social Media Moderators: Justin Chee, Australia / John Davis, United States

At the end of this session, the learner will:

  • Learn the varied germline and somatic mutations in urologic cancers.
  • Associate therapeutic response and clinical outcomes with differing mutational profiles.
  • Gain insight into the development of new biomarker assays that will stratify patients.
  • Realize that molecular classifications of urologic cancers are driving therapeutic selection.
  • Identify patients suitable for active surveillance for prostate cancer
  • Discuss the emerging role of radical prostatectomy for oligo-metastatic prostate cancer
  • Describe the components of enhanced recovery pathways in urological surgery
  • Describe several currently applied therapeutic modalities that use a tissue-engineered construct.
  • Understand design of implantable tissue-engineered grafts that exhibit characteristics consistent with the physiology and function of the equivalent healthy native tissue.
  • Explore the use of porcine small intestinal submucosa (SIS) and bladder ECM grafts, which have garnered significant attention.
  • Comprehend how seeded constructs vs. unseeded technology has potential as an application in tissue engineering.
  • Discuss ongoing clinical trials (Urological Disease Clinical Trials) such as:
    • Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora.
    • Multisystem Cell Therapy for Improvement of Urinary Continence
    • Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
    • Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
0830-0915    

Interpretation and Clinical Implication of Cancer Genetics in Uro-Oncology

Moderator: Christopher Evans, United States
   

Prostate Cancer

Seok Soo Byun, South Korea
   

Renal Cell Carcinoma

Bradley Leibovich, United States
   

Bladder Cancer

Piyush Agarwal, United States
0915-1000    

Oncology Updates

Moderator: Monish Aron, United States
   

PRIAS-JAPAN Study

Mikio Sugimoto, Japan
   

Oligomets RARP

Isaac Kim, United States
   

ERAS Protocol

Jay Shah, United States
   

Oncology Updates - Audience Polling

Monish Aron, United States
1000-1020    

SIU-Dr. Mostafa M. Elhilali Lecture

   

Urologists vs Urinary Bugs: Time for a Truce?

1020-1040    

Panel—Cell Therapy and Constructs: Why Is It Not Yet In Clinical Use?

Moderator: Karl-Dietrich Sievert, Germany
Panelists
Yun Seob Song, South Korea
James Yoo, United States
1040-1055    

European Association of Urology Lecture

   

What is the Role of Radical Prostatectomy in Locally Advanced and Oligo Metastatic Prostate Cancer?

Manfred Wirth, Germany
1055-1110    

State of the Art Lecture

   

Advances in Robotic Surgery in 2018

Koon Ho Rha, South Korea

0845-1145

INN: Cambridge Prostate MRI Workshop  

Room: 3F Shilla 1/2/3
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom

Based on the Cambridge Prostate MRI & Biopsy Workshop.

Pre-registration required for this workshop.

1110-1130

Break in Exhibit Hall  

Room: 3F Hanra

1115-1130

SIU@U: SIU@U Session | SIU Academy Awards    

Room: SIU Booth
Host: Dean Elterman, Canada

1130-1300

MP-01: Moderated ePoster Session 01—Outstanding Abstracts  

Room: 5F Goguryeo 1
Moderators: Sanjay Kulkarni, India / Kyu-Sung Lee, South Korea / Simon Tanguay, Canada

To view a list of scheduled presentations for this session, please click here

1130-1300

JS01: Joint SIU-SURS Symposium: Robotic Innovations in Urology    

Room: 5F Baekdu A+B
Co-Chairs: John Davis, United States / René Sotelo Noguera, United States
Social Media Moderator: Ardeshir Rastinehad, United States

At the end of this session, the learner will:

  • State what's new in urologic robotic Surgery
  • Recognize emerging procedures in robotic surgery
  • Recall technical tips and tricks for current robotic procedures
1130-1142    

Novel Intraoperative Imaging Modalities during Robotic Surgery

Lance Hampton, United States
1145-1157    

Robotic Partial Nephrectomy: How to Optimize Renal Function Preservation

Riccardo Autorino, United States
1200-1212    

The Rise of Robotic Simple Prostatectomy: Tips and Tricks

René Sotelo Noguera, United States
1215-1227    

Novel Approaches for Robotic Radical Prostatectomy

Koon Ho Rha, South Korea
1230-1242    

Intracorporeal Urinary Diversion: An Effective Alternative

John Davis, United States
1245-1257    

Robotic Single Port Surgery is Coming Back: New Systems and New Techniques

Eddie Chan, Hong Kong

1130-1130

JS02: Joint SIU-Endourology Symposium  

Room: 5F Baekdu C
Co-Chairs: Olivier Traxer, France / Michael Wong, Singapore
Social Media Moderator: Sung Yong Cho, South Korea

At the end of this session, the learner will:

  • Identify the factors behind the choices for buying your next Ureteroscope and Nephroscope using a debate format for discussion.
  • Redefine the Optimal Holmium Laser settings for endourological procedures today.
  • Learn and apply the lessons learned in the optimal usage of Ureteral Access Sheaths in the past decade.
1130-1150    

Panel Discussion—The Evolution of Ureteroscopy: Robotic, Disposable, Micro-URS—Are We Off Track?

   

I am a Traditional Urologist: Reusable Devices

Michael Grasso, United States
   

I am a “Fed-up with Breakage” Urologist: Single-Use and Robotic Devices

Petrisor Aurelian Geavlete, Romania
1150-1210    

Debate—Does Tract Size and Intra-renal Pressures Matter in PCNL?

   

I like Normal Size

Sung Yong Cho, South Korea
   

I like a Smaller Size

Norberto Bernardo, Argentina
1210-1230    

The Final Statement on Ureteral Access Sheath—Does it Do More Harm than Good?

Michael Wong, Singapore
1230-1250    

Have We Optimized Holmium Laser Settings in Urology?

Olivier Traxer, France
1250-1300    

Discussion

1215-1615

INN: SIU Innovators MRI-TRUS Fusion Hands-On Course  

Room: 3F Shilla 1/2/3
Co-Chairs: Peter Black, Canada / Christof Kastner, United Kingdom

Pre-registration is required for this course.

1300-1415

Lunch Break  

Room: 3F Hanra

1415-1545

IC01: Instructional Course 01—Medical Treatment of CRPC  

Room: 3F Shilla 4
Chair: Damien Bolton, Australia

At the end of this session, the learner will:

  • Describe the natural course of prostate cancer with particular emphasis upon the acquisition of castrate resistant disease.
  • Explain the implications of castrate resistance on the management of prostate cancer in regard to medical and surgical needs.
  • Be aware of specific recommendations and guidelines for patient management within this area of practice.
  • Understand the roles for recently approved therapeutics for CRPC.
  • Contrast the mechanisms of action and clinical efficacy of such therapeutics for CRPC.
  • Appraise immunosuppressive agents and other novel therapeutic groups used in the treatment of CRPC.
  • Integrate advances in bone health management into patient care.
  • Proactively manage comorbidities, and also the side effects of medications used for the treatment of CRPC.
1415-1420    

Introduction

Damien Bolton, Australia
1420-1435    

Chemotherapy for CRPC: Which Patient and When?

Nathan Lawrentschuk, Australia
1435-1450    

Immunotherapy for Castrate Resistant Prostate Cancer

Sung Kyu Hong, South Korea
1450-1505    

Clinical Implications of Genomic Sequencing in CRPC

Christopher Evans, United States
1505-1520    

How to Initiate Urologist-Directed Management of CRPC

Manish Patel, Australia
1520-1530    

Discussion

1415-1545

IC02: Instructional Course 02—Male Infertility and Varicoceles  

Room: 4F Baekje 2/3/4
Co-Chairs: Joel Marmar, United States / Mohammad Ali Sadighi Gilani, Iran

At the end of this session, the learner will:

  • Identify and differentiate the current tests that are available to evaluate the basis of infertility associated with varicoceles.
  • Understand the pathologic factors associated with varicoceles.
  • Compare and evaluate the current treatments for the correction of varicoceles.
1415-1420    

Introduction

Joel Marmar, United States
1420-1435    

Drug Therapy for Varicocele Induced Infertility

Sidney Glina, Brazil
1435-1450    

Varicocelectomy and DNA Fragmentation

Gholamreza Pourmand, Iran
1450-1505    

Surgery is Useful in Azoospermic Men

William Huang, Taiwan
1505-1520    

Doing the Surgery Right

Joel Marmar, United States
1520-1535    

Pregnancy Data on Varicocele Surgery

Rajeev Kumar, India
1535-1545    

Audience Polling

Joel Marmar, United States

1415-1545

MP-02: Moderated ePoster Session 02—Basic Science  

Room: 5F Goguryeo 1
Moderators: Piyush Agarwal, United States / Ji-Kan Ryu, South Korea

To view a list of scheduled presentations for this session, please click here

1415-1545

MP-03: Moderated ePoster Session 03—BPO/LUTS  

Room: 5F Goguryeo 2
Moderators: Henry Ho, Singapore / Seung-June Oh, South Korea

To view a list of scheduled presentations for this session, please click here

1415-1545

MP-04: Moderated ePoster Session 04—Stones  

Room: 5F Goguryeo 3
Moderator: Sung Yong Cho, South Korea

To view a list of scheduled presentations for this session, please click here

1415-1545

CONT01: Controversies in Urology 1—Urethroplasty  

Room: 5F Baekdu C
Co-Chairs: Frank Burks, United States / Sanjay Kulkarni, India
Social Media Moderator: Justin Chee, Australia

At the end of this session, the learner will:

  • Have a better understanding of the use of tissue grafts and tissue flaps for the management of urethral stricture disease.
  • Increase their knowledge with regards to the use of grafting in urethroplasty and anastomotic urethroplasty.
  • Have an improved understanding of the benefits and advantages of a simple vs elaborated perineal approach for urethroplasty.
  • Gain a better understanding of the management of lichen sclerosis with a single stage urethroplasty vs two stage urethroplasty.
1415-1418    

Introduction

1418-1438    

Bulbar Urethra: Graft vs. Anastomosis

   

Graft

Justin Chee, Australia
   

EPA

Michael Coburn, United States
1438-1458    

Grafts vs. Flaps

   

Grafts

Jeremy Myers, United States
   

Flaps

1458-1518    

Penile Urethral Stricture due to Lichen Sclerosus: Two Stage vs Single Stage Repair

   

Two Stage

Ramon Virasoro, United States
   

Single Stage

Dmitriy Nikolavsky, United States
1518-1538    

PFUD: Simple vs. Elaborated Perineal Approach

   

Simple

Francisco E. Martins, Portugal
   

Elaborated

Anthony Mundy, United Kingdom
1538-0000    

Summary and Closing Remarks

1415-1735

SMV01: Surgical Masters Videos 1—Laparoscopy    

Room: 5F Baekdu A+B
Co-Chairs: Koon Ho Rha, South Korea / René Sotelo Noguera, United States

At the end of this session, the learner will:

  • Recall with the most commonly performed laparoscopic procedures.
  • Recognize/prevent complications during laparoscopic surgery
  • Manage intraoperative laparoscopic complications 
1415-1435    

Robotic Radical Prostatectomy

Gyung Tak Mario Sung, South Korea
1435-1455    

Robotic Simple Prostatectomy

René Sotelo Noguera, United States
1455-1515    

Robotic Pyeloplasty and Ureteral Reconstruction

Mihir Desai, United States
1515-1535    

Laparoscopic Radical Nephrectomy: Step-by-Step

Mallikarjuna Chiruvella, India
1535-1555    

Robotic Partial Nephrectomy

Koon Ho Rha, South Korea
1555-1615    

Robotic Kidney Transplant

Presenter: René Sotelo Noguera, United States
1615-1635    

Robotic Salvage Prostatectomy: Tips and Tricks

Monish Aron, United States
1635-1655    

Laparoscopic and Robotic Adrenalectomy

Rajeev Kumar, India
1655-1715    

Laparoscopic and Robotic Vesico-Vaginal Fistula Repair

René Sotelo Noguera, United States
1715-1735    

Endoscopic Inguinal Lymphadenectomy

Victor Enrique Corona Montes, Mexico

1545-1605

Break in Exhibit Hall  

Room: 3F Hanra

1605-1735

DEMO: Demo Session | Tips and Tricks in FURS  

Room: 4F Baekje 6

Pre-registration is required for this session.

1605-1735

IC03: Instructional Course 03—Treatment of Urolithiasis in 2018: Could We Do It Better?  

Room: 3F Shilla 4
Chair: Kevin Lu, Taiwan

At the end of this session, the learner will:

  • Describe, in general, the current status of urolithiasis in real-world, and accurate evaluation of patients with urolithiasis
  • Contrast risks and benefits of different treatment options and recognize how to avoid and manage treatment-associated complications
  • Establish efficient facility and team to perfect RIRS and PNL step by step
  • Discuss treatment options with patients to inform decision-making
1605-1610    

Opening Remarks

Kevin Lu, Taiwan
1610-1630    

Urolithiasis in Clinical Vignettes: More than Meets the Eye

Kevin Lu, Taiwan
1630-1650    

Tips and Tricks of Retrograde Intrarenal Surgery (RIRS): How To Establish and Perfect an Efficient Facility

Hung-Chieh Chiu, Taiwan
1650-1710    

PNL in 2018: Where Are We Headed? Less is More?

Hsin-Wei Shih, Taiwan
1710-1730    

Panel Discussion

1730-1735    

Summary and Conclusion

Kevin Lu, Taiwan

1605-1735

MP-05: Moderated ePoster Session 05—Prostate Cancer: Basic Science  

Room: 5F Goguryeo 1
Moderators: Wun-Jae Kim, South Korea / Arturo Mendoza-Valdes, Mexico

To view a list of scheduled presentations for this session, please click here

1605-1735

MP-06: Moderated ePoster Session 06—Adrenal and Andrology  

Room: 5F Goguryeo 2
Moderators: Ajay Nehra, United States / Kwangsung Park, South Korea

To view a list of scheduled presentations for this session, please click here

1605-1735

MP-07: Moderated ePoster Session 07—Imaging/Radiology  

Room: 5F Goguryeo 3
Moderators: Peter Hammerer, Germany / Seung-Hyup Kim, South Korea

To view a list of scheduled presentations for this session, please click here

1605-1735

IC04: Instructional Course 04—Female Urethral Reconstruction  

Room: 4F Baekje 2/3/4
Chair: Kurt McCammon, United States

At the end of this session, the learner will:

  • Describe the incidence and evaluation of female urethral strictures
  • Describe the surgical options including dorsal and ventral Grafts and flaps. 
  • Review the etiology of traumatic strictures and their treatment. 
1605-1610    

Introduction

Kurt McCammon, United States
1610-1630    

Epidemiology Evaluation and Diagnosis

1630-1650    

Surgical Management

Kurt McCammon, United States
1650-1710    

Traumatic Urethral Stricture

Nikhil Khattar, India
1710-1735    

Case Presentations

Discussants
Nikhil Khattar, India
Kurt McCammon, United States

1605-1735

CONT02: Controversies in Urology 2—Testis Cancer    

Room: 5F Baekdu C
Co-Chairs: Jens Bedke, Germany / Andrea Necchi, Italy
Social Media Moderator: Shomik Sengupta, Australia

At the end of this session, the learner will:

  • Decide the optimal treatment strategy in testis cancer clinical stage I
  • Identify risk factors of relapse in CSI and will be able to judge the prognosis in TC CSI.
  • Repeat currently used biomarkers and be able to recognize new biomarkers in TC for the future.
1605-1650    

Management of Clinical Stage I in Seminoma and Non-seminoma:

   

Surveillance

Karim Touijer, United States
   

RPLND

Yao Zhu, China
   

Chemo

Andrea Necchi, Italy
1650-1710    

The Future of Biomarkers to Guide Therapy and Follow-up

Jens Bedke, Germany
1710-1735    

Question and Answer


Saturday, October 06

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0730-0830

SIU General Assembly  

Room: 5F Goguryeo 2

0730-0830

MC04: Master Class 4—Bladder Cancer: Robot Assisted Laparoscopic Radical Cystectomy and Urinary Diversions  

Room: 4F Baekje 2/3/4
Co-Chairs: Ashish M. Kamat, United States / Raj Pruthi, United States

At the end of this session, the learner will:

  • Identify the role of robotics in bladder cancer surgery including indications and approaches to robotic cystectomy.
  • Recognize potential complications associated with robotic bladder cancer surgery (including diversion) and develop skills and approaches to avoid such complications.
  • Be able to perform complex robotic bladder cancer surgery (cystectomy and urinary diversion) with a comprehension of the work-up and surgical steps of the procedures.
0730-0735    

Introduction

Ashish M. Kamat, United States
Raj Pruthi, United States
0735-0745    

Key Steps of Robotic Radical Cystoprostatectomy and ePLND (Extirpative)

Gagan Gautam, India
0745-0755    

Key Steps of Robotic Anterior Pelvic Exenteration (RARC in XRT Patient)

Jeffrey Nix, United States
0755-0800    

Question and Answer

0800-0810    

Intracorporeal Ileal Conduit

Mihir Desai, United States
0810-0820    

Intracorporeal Neobladder

Giuseppe Simone, Italy
0820-0825    

Question and Answer

0825-0830    

Summary

Ashish M. Kamat, United States
Raj Pruthi, United States

0730-0830

MC05: Master Class 5—Stones: Surgical Guidelines and Techniques (Ureter)  

Room: 3F Shilla 4
Co-Chairs: Norberto Bernardo, Argentina / Anthony Chi-Fai Ng, Hong Kong

At the end of this session, the learner will:

  • The role of safety guidewire during the uretroscopy
  • The controversies related to the use of access sheath during ureteroscopy
  • The use of stents before and after ureteroscopy
  • The latest development in rigid ureteroscopy
0730-0742    

To Stent or Not To Stent?

Sung Yong Cho, South Korea
0745-0757    

Sheath vs. No Sheath (RIRS)

Anthony Chi-Fai Ng, Hong Kong
0800-0812    

Is Safety Guide Wire Still Needed?

Norberto Bernardo, Argentina
0815-0827    

Is the Rigid Ureteroscope Still Alive?

Shuji Isotani, Japan

0730-0830

MC06: Master Class 6—Advanced Diagnostic and Interventional Imaging in Urology  

Room: 5F Goguryeo 1
Co-Chairs: Krishnanath Gaitonde, United States / Dan Rukstalis, United States

At the end of this session, the learner will:

  • Understand the clinical application of multiparametric ultrasound as an emerging diagnostic and interventional modality for prostate cancer
  • Be able to define the role of PET and flouroscence imaging in the management of recurrent and advanced prostate cancer
  • Understand how imaging can be utilized to characterize tissue architecture in determining the malignant potential of renal tumors
0730-0735    

Introduction

Krishnanath Gaitonde, United States
Dan Rukstalis, United States
0735-0750    

Multiparametric Ultrasound in Diagnosis of Prostate Cancer

Dan Rukstalis, United States
0750-0805    

PET and Fluorescence Imaging for Recurrent/Advanced Prostate Cancer

Jun Miki, Japan
0805-0820    

Advances in Renal Imaging for Tumor Tissue Characterization

Krishnanath Gaitonde, United States
0820-0830    

Question and Answer

0800-1530

NURS: 4th Global Urology Nurses’ Symposium  

Room: 4F Baekje 6
Chair: Kay Talbot, Australia
0800-0805    

Welcome

0805-0845    

The Transition from Trans Rectal Prostate Biopsy to Transperineal Prostate Biopsy–Implications on Care

Jeremy Grummet, Australia
0845-0930    

Does Confusion Continue to Surround Catheter Care?

Khatijah Abdullah, Malaysia
Azad Hassan Abdul Razack, Malaysia
0930-1015    

Lower Urinary Tract Symptoms (LUTS) including Benign Prostate Hypertrophy (BPH)

Jaspreet S. Sandhu, United States
1015-1045    

Moderated ePoster Presentations

1015-1020    

NURS-01: The Effect of Kegel Exercise with Different Intensities on Patients with Stress Urinary Incontinence

Presenter: Xiaoqin Chen, China
1020-1025    

NURS-02: Effect of Omaha System in the Continuity Nursing of Patients with Sacral Nerve Regulator Implantation

Presenter: Xin Cheng, China
1025-1030    

NURS-03: Short-term Removal Protocol of Indwelled Urethral Catheter Applied in Partial Nephrectomy Patients After Surgery

Presenter: Jie Cao, China
1030-1035    

NURS-04: Study of Perioperative Fast Track Surgery Nursing for Benign Prostatic Hyperplasia Treated with 1470nm Diode Laser Enucleation of the Prostate

Presenter: Li Zhang, China
1035-1040    

NURS-05: Younger Patients is More Easy to Get Depressive Disorders by Non-neoplastic Nephrectomy

Presenter: Shanhua Mao, China
 

Break and ePoster Viewing

   

Oral Abstract Presentations

Moderator: Vashti Livingston, United States
1100-1110    

NURS-06: Evaluation of the Service Outcomes of the Urology Nurse Clinic for Female Patients with Urinary Retention

Presenter: Kwok Kin Leung, China
1110-1120    

NURS-07: Evaluation of Nutrition Support in the Enhanced Recovery after Surgery Program for Perioperative Prostate Cancer Patients

Presenter: Xiaoling Qu, China
1120-1130    

NURS-08: The Study on the Process Optimization of Painless Transperineal Prostate Biopsy under TRUS Guidance

Presenter: Husheng Li, China
1130-1140    

NURS-09: The Application of Bundle Nursing in the Prevention of Postoperative Urination Dysfunction of Orthotopic Neobladder

Presenter: Xuemei Li, China
1140-1150    

NURS-10: Qualitative Analysis of Factors Influencing the Prostate Cancer Patients’ Participation Degree Toward the Decision-Making Process of Operative Treatment

Presenter: Jie Cao, China
1150-1200    

NURS-11: Does Postoperative Rehabilitation for Radical Cystectomy call for Enhanced Recovery after Surgery? A Systematic Review and Meta-Analysis

Presenter: Jun Xiao, China
1200-1210    

NURS-12: A Nursing Intervention for Enhancing the Self-efficacy and Life Quality of Patients with Bladder Cancer and Urostomy in Beijing, China

Presenter: Jing Huang, China
 

Break and ePoster Viewing

1315-1415    

Wound Management: Current Generation Dressings

Vashti Livingston, United States
1415-1435    

Managing Quality of Life for Men on Androgen Deprivation Therapy

Kay Talbot, Australia
1435-1510    

Discussing Sexual Function after Treatment for Prostate Cancer

Chi Kwok Chan, China
1455-1530    

Creating and Managing Patient Expectations

Haengah Lee, South Korea
Arveen Kalapara, Australia
Haeng Ah Yi, South Korea
1530-1530    

Adjourn

0830-1100

PL02: Plenary 2    

Room: 5F Baekdu A+B
Honorary Chairs: Peter Hammerer, Germany / Simon Tanguay, Canada
Social Media Moderator: Dean Elterman, Canada

At the end of this session, the learner will:

  • Delineate the overlapping nature of functional urology and the impact of that overlap with recognized lower urinary tract syndromes
  • Define and understand the variability of pelvic floor and sphincteric dysfunction associated with Spinal Cord Injury
  • Appreciate the causes, impacts and treatments for nocturia in adults
  • Understand the concept of the topics discussed and would be much more confident in taking the decisions in their day to day practice
  • Be in a position to make the decision on which treatment modality would be the ideal one
  • Be able to reduce the damage of flexible ureteroscopes in day to day practice
  • Understand the philosophy of managing those stones by various experts
0830-0920    

Functional Urology

Moderator: Roger Dmochowski, United States
0830-0845    

Is the Detrusor Muscle the Target of Therapy for Lower Urinary Tract Symptoms?

0845-0900    

External Sphincter Behavior in SCI, Dysfunctional Voiding and Pelvic Floor Weakness

John Heesakkers, The Netherlands
0900-0920    

Nocturia

Alan Wein, United States
0920-1020    

Stones

Moderators
Mallikarjuna Chiruvella, India
Guohua Zeng, China
   

Algorithm to Treat Calyceal Diverticular Stones: PCNL vs RIRS?

Olivier Traxer, France
   

Tactics to Reduce Scope Damage: Ideal Versus Practical

Pankaj Maheshwari, India
   

Panel: Perioperative Management of Retained Stones—Complicated Cases

Moderator: Madhu Sudan Agrawal, India
Panelists
Joel Aldana, Philippines
Norberto Bernardo, Argentina
John Denstedt, Canada
1020-1030    

SIU Best Video Award

Honorary Chair: Simon Tanguay, Canada
1030-1045    

Confederación Americana de Urología Lecture

   

Robotic Assisted Radical Cystectomy: Present and Future

Alejandro Rodriguez, United States
1045-1100    

Urological Association of Asia Lecture

   

Introduction

Allen W. Chiu, Taiwan
   

Physical Energy Therapy for Prostate Cancer

Yinghao Sun, China

0845-1145

INN: Cambridge Prostate MRI Workshop  

Room: 3F Shilla 1/2/3
Co-Chairs: Tristan Barrett, United Kingdom / Christof Kastner, United Kingdom

Based on the Cambridge Prostate MRI & Biopsy Workshop.

Pre-registration required for this workshop.

1100-1130

Break in Exhibit Hall  

Room: 3F Hanra

1110-1125

SIU@U: SIU@U uTalks | Tracing the Tumors: The Hype of Molecular Imaging  

Room: SIU Booth
Speaker: Karim Touijer, United States

1130-1300

DEMO: Demo Session | Tips and Tricks in FURS  

Room: 3F Shilla 4

Pre-registration is required for this session.

1130-1300

JS03: Joint SIU-GURS Symposium: Male Urogenital Trauma  

Room: 5F Baekdu A+B
Chair: Michael Coburn, United States

At the end of this session, the learner will:

  • Describe the surgical options as well as pros and cons for penile reconstruction either phalloplasty or penile transplant.
  • Understand the up to date management of GU trauma
  • Describe the treatment options for genital lymphedema
1130-1200    

Penile Transplant vs Phallic Reconstruction

   

Transplant

André van der Merwe, South Africa
   

Reconstruction

   

Rebuttal

André van der Merwe, South Africa
   

Rebuttal

   

Questions and Discussion

1200-1220    

Genital Lymphedema: Lessons Learned from Ghana

Ben Adusei, Ghana
1220-1240    

Fournier’s Gangrene: Acute and Chronic

Ramon Virasoro, United States
1240-1300    

Genitourinary Trauma Update

Michael Coburn, United States

1130-1300

JS04: Joint SIU-ESOU-SUO Symposium    

Room: 5F Baekdu C
Co-Chairs: Maurizio Brausi, Italy / Christopher Evans, United States

At the end of this session, the learner will:

  • Understand the utility of prostate cancer biomarkers.
  • Recognize the cost of biomarker assays and their potential cost benefit.
  • Comprehend the strengths and limitations of MRI as an initial test for elevated PSA.
  • Recognize the balance of treatment of renal cell cancer with toxicities in the elderly patient.
  • Realize the benefits and limitations of bladder sparing surgery for muscle invasive bladder cancer as it particularly relates to the elderly patient.
1130-1210    

Biomarkers and MRI Pre-biopsy in the Patient with an Elevated PSA

Moderator: Jason Letran, Philippines
   

Biomarkers Are Cost Effective and Useful in Patient Selection

Derya Tilki, Germany
   

MRI Should Be Performed in All Patients Prior to Biopsy

Jun Hyuk Hong, South Korea
   

Case Panel Discussion

1210-1230    

Nephron Sparing Surgery in the Patient Over 75 Years of Age

Moderator: Christopher Evans, United States
   

State of the Art Lecture: Nephron Sparing Surgery in the Patient Over 75 Years of Age

Peter Mulders, The Netherlands
   

Discussion

1230-1300    

Issues and Controversies in Bladder Cancer

Moderator: Maurizio Brausi, Italy
   

High Grade T2 UCC of the Bladder in a 75-Year-Old Patient—Debate: Bladder Sparing Surgery

   

Pro

Rainy Umbas, Indonesia
   

Con

Badrinath Konety, United States
   

Discussion

1215-1615

INN: SIU Innovators MRI-TRUS Fusion Hands-On Course  

Room: 3F Shilla 1/2/3
Co-Chairs: Peter Black, Canada / Christof Kastner, United Kingdom

Pre-registration is required for this course.

1300-1415

Lunch Break  

Room: 3F Hanra

1415-1545

IC05: Instructional Course 05—Upper Tract TCC Management In 2018: Current Perspective  

Room: 3F Shilla 4
Chair: Makarand Khochikar, India

At the end of this session, the learner will:

  • Identify the newer concepts in the upper tract urothelial carcinoma in terms of biological behaviour
  • Appreciate the limitations of the current investigative modalities and treatment
  • Analyze the concept of conservative treatment in upper tract UC
  • Critically analyze the results of adjuvant chemotherapy in the post nephreuretectomy status in upper tract UC
1415-1435    

Is it an Aggressive Disease?

Raj Pruthi, United States
1435-1455    

Diagnosis and Staging: The Pitfalls and the Challenges

Jean de la Rosette, Türkiye
1455-1515    

Conservative Management in Upper Tract TCC

Makarand Khochikar, India
1515-1535    

Adjuvant Therapy after Radical Nephreureterectomy: Where Is the Evidence

Badrinath Konety, United States

1415-1545

MP-08: Moderated ePoster Session 08—Pediatric Urology and Infections  

Room: 5F Goguryeo 1
Moderators: Christopher Cheng, Singapore / Kwanjin Park, South Korea

To view a list of scheduled presentations for this session, please click here

1415-1545

MP-09: Moderated ePoster Session 09—Prostate Cancer: Intervention  

Room: 5F Goguryeo 2
Moderators: Jun Hyuk Hong, South Korea / Peter Mulders, The Netherlands

To view a list of scheduled presentations for this session, please click here

1415-1545

MP-10: Moderated ePoster Session 10—Bladder and Penile Cancer  

Room: 5F Goguryeo 3
Moderators: Ioannis Gkialas, Greece / Sun Il Kim, South Korea

To view a list of scheduled presentations for this session, please click here

1415-1545

IC06: Instructional Course 06—Donor Nephrectomy  

Room: 4F Baekje 2/3/4
Co-Chairs: Hyuk jin Cho, South Korea / Aneesh Srivastava, India

At the end of this session, the learner will:

  • Recall how to prepare a donor for surgery and how to perform a safe surgery.  
  • List precautions required in selecting a potential donor as per the current international guidelines and standards and describe various surgical options from open to minimally invasive surgery to remove the kidney.
  • Apply adequate surgical knowledge that would help them to safely assist and perform such surgical procedures.
1415-1435    

Robotic and Laparoscopic Donor Nephrectomy

Hyuk jin Cho, South Korea
1435-1443    

Hand-Assisted Laparoscopic Retrieval

Ki Soo Lee, South Korea
1445-1500    

Open Donor Nephrectomy

Aneesh Srivastava, India
1500-1520    

The Current International Guidelines on the Care of the Kidney Donor

Sanjay Pandey, India
1520-1535    

Summation and Audience Polling

Aneesh Srivastava, India
1535-1545    

Discussion/Case Presentation

1415-1545

CONT03: Controversies in Urology 3—Urethral Diverticulum  

Room: 5F Baekdu C
Chair: Roger Dmochowski, United States
Social Media Moderator: Amanda Chung, Australia

At the end of this session, the learner will:

  • Define the use of imaging modalities in the diagnosis of urethral diverticula
  • Understand the potential for non-surgical therapy for urethral diverticula
  • Select and enumerate the best surgical options for urethral diverticula
  • List the functional outcomes of importance for any intervention for urethral diverticula
1415-1435    

Evaluation Including Use of Advanced Imaging

John Heesakkers, The Netherlands
1435-1455    

The Case for Conservative Managements

Gopal Badlani, United States
1455-1515    

Surgical Options and Results – Is There a Best Way?

Janice Cheng, Australia
1515-1535    

Functional Outcomes and How to Optimize, with Emphasis on Continence and Sexual Function

Satoru Takahashi, Japan
1535-1545    

Discussion

1415-1545

SMV02: Surgical Masters Videos 2—Male Voiding Complications after Prostate Treatment  

Room: 5F Baekdu A+B
Co-Chairs: Jaspreet S. Sandhu, United States / Ajay Singla, United States

At the end of this session, the learner will:

  • To understand the urinary complications following prostate surgery.
  • To learn about Bladder neck contracture after prostatectomy and its related complications and management.
  • To learn regarding male sling and management of complications.
  • To learn about adjustable male sling and management of complications following prostatectomy.
  • To learn about the management of post-prostatectomy incontinence by AUS implantation and related complications.
1415-1435    

Artificial Urinary Sphincter Placement Including Trouble Shooting AUS Malfunction

Sean P. Elliott, United States
1435-1455    

Transobturator Male Sling Placement

Kurt McCammon, United States
1455-1515    

Adjustable Male Sling Placement

Javier Angulo, Spain
1515-1535    

Open/Robotic Anastomotic Stricture Repair

Jeremy Myers, United States

1430-1500

SIU@U: SIU@U Session | uChallenge—Residents Rapid Fire Q&A    

Room: SIU Booth
Host: Dean Elterman, Canada

1545-1600

SIU@U: SIU@U uTalks | Why is Perioperative Patient Education Important?    

Room: SIU Booth

Sunday, October 07

Please click on the session titles to view the session details when available.
Session will be presented on the SIU@U App included with your congress registration.

0730-0830

IC07: Instructional Course 07—Management of Urinary Complications after Prostatectomy  

Room: 5F Goguryeo 1
Chair: Jaspreet S. Sandhu, United States

At the end of this session, the learner will:

  • Understand complex etiology of urinary incontinence after prostatectomy   
  • Identify issues in management of incontinence after prostatectomy.   
  • Develop an algorithm for management of recalcitrant anastomotic strictures   
  • Identify treatment options for urinary fistula including reconstructive procedures and indications for urinary diversion 
   

Faculty

William J. Lynch, Australia
0820-0830    

Audience Polling and Discussion

Jaspreet S. Sandhu, United States

0730-0830

MC07: Master Class 7—Case-Based Management: Bladder Cancer  

Room: 4F Baekje 2/3/4
Co-Chairs: Badrinath Konety, United States / Giuseppe Simone, Italy

At the end of this session, the learner will:

  • Recall indication to neoadjuvant chemotherapy before radical cystectomy, proper extent of pelvic lymph node dissection, selection of patient tailored urinary diversions.
  • Analyze reasons behind differences in approach to presented cases.
  • Recognize high quality evidences and technical supports for managing muscle invasive bladder cancer patients
   

Panelists

Piyush Agarwal, United States
Monish Aron, United States
Michael Rink, Germany
0730-0735    

Introduction

Badrinath Konety, United States
Giuseppe Simone, Italy
0735-0745    

Case 1: Pro and cons of Neoadjuvant Chemotherapy cT2/cN0/M0 –> NACT –> leucopenia and delayed radical cystectomy

Michael Rink, Germany
0745-0755    

Case 2: Optimal Extent of PLND cT3/cN3/M0 –> NACT –>partial response (cT0/N2/M0)

Piyush Agarwal, United States
0755-0810    

Case 3: Sex Sparing RC: Open? Robotic? cT2/cN0/M0, young female –> Video-based Presentation (Sex Sparing and Neobladder)

Monish Aron, United States
0810-0825    

Case 4: Continent Cutaneous Urinary Diversions cT4a/cN0/M0, young male/female –> NACT –> Partial Response but Persistent Disease at Prostate/Urethral Margin: Conduit or Continent Diversion?

0825-0830    

Conclusions

Badrinath Konety, United States
Giuseppe Simone, Italy

0730-0830

MC08: Master Class 8—Case-Based Management of Complex Stones  

Room: 3F Shilla 4
Co-Chairs: John Denstedt, Canada / Athanasios (Thanos) Papatsoris, Greece

At the end of this session, the learner will:

  • Be familiar with indications and options for the management of complex renal and ureteral calculi.
  • Establish an effective algorithm for management of complex stones including cystine and radiolucent stones, calculi in anomalous anatomy and in anticoagulated patients.
  • Understand technical aspects and variations in approaches to URS and PCNL in complex stone cases. 
0730-0745    

Anticoagulation and Stones

Norberto Bernardo, Argentina
0745-0800    

Stones in Pregnancy

Anthony Chi-Fai Ng, Hong Kong
0800-0815    

Anomalous Kidney

0815-0830    

Diversion and Stones

Guohua Zeng, China

0830-1110

PL03: Plenary 3    

Room: 5F Baekdu A+B
Honorary Chairs: Jean de la Rosette, Türkiye / Sanjay Kulkarni, India
Social Media Moderators: Sung Yong Cho, South Korea / Imogen Patterson, Australia / Faysal Yafi, United States

At the end of this session, the learner will:

  • Summarize the history of robotic systems to the present.
  • Compare the different robotic systems available for urologic surgery.
  • Discuss the various urological procedures that can be done on the different robotic systems
  • Summarize worldwide perspectives on Men's Health
  • Relate the importance of Men's Health in Urological Practice and Urological Research
  • Identify the aspects of Men's Health they could focus on to improve their individual practices or as research objectives.
  • Review basic laser physics and current prostate enucleation techniques.
  • Discuss Bipolar, Robotic, Holmium-LEP (HoLEP), Aqua Ablation, Thulium-LEP (ThuLEP), Greenlight-LEP (GreenLEP) and traditional techniques (TURP)
  • Summarize current literature with respect to functional outcomes and complications.
0830-0855    

New Robotic Devices

John Davis, United States
0855-0925    

Men's Health Panel

Moderator: Serigne Magueye Gueye, Senegal
Panelists
Lukman Hakim, Indonesia
Ajay Nehra, United States
0925-1010    

BPH Panel: Enucleation Techniques

Moderator: Jaspreet S. Sandhu, United States
   

Bipolar

Li-Ping Xie, People's Republic of China
   

Robotic

Thomas Guzzo, United States
   

Holmium

Anil Kumar Varshney, India
   

Aqua Ablation

Peter Gilling, New Zealand
   

GreenLight Laser

Vincent Misrai, France
   

Is There a Role for Open?

Oussama Elhage, United Kingdom
1010-1025    

SIU-Albert Schweitzer Award Lecture

   

Is the Spirit of Albert Schweitzer Outdated in 2018?

Alain Le Duc, France
1025-1040    

American Urological Association Lecture

   

Bladder Exstrophy: Global Solutions for a Global Problem

Aseem Shukla, United States
1040-1055    

Pan-African Urological Surgeons' Association Lecture

   

Surgical Management of BPH in Africa: The Way Forward

Mobile Kampanga, Democratic Republic of Congo
1055-1110    

Global Philanthropic Committee Presentation

Simon Tanguay, Canada

1110-1130

Break  

Room: 5F Baekdu D

1130-1300

INN: Resident Mentoring Session  

Room: 3F Shilla 1/2/3
Moderator: M. Hadi Radfar, Iran

The session will feature 9 experts paired up with up to 3 trainees. The group of trainees will have 8 minutes with each expert to ask questions and seek advice regarding career planning and goals. 

   

Experts

Jens Bedke, Germany
Damien Bolton, Australia
Joseph Chin, Canada
John Davis, United States
Seok Ho Kang, South Korea
Sanjay Kulkarni, India
Pilar Laguna, Türkiye
Athanasios (Thanos) Papatsoris, Greece
André van der Merwe, South Africa

1130-1300

JS05: Joint SIU-ICS Symposium  

Room: 5F Baekdu A+B
Co-Chairs: Elise De, United States / Sherif Mourad, Egypt

At the end of this session, the learner will:

  • Identify global considerations in neurogenic bladder and fistula, and begin to apply these considerations in care of patients from these regions, whether in home clinics or in mission work.
  • Describe special considerations in the care of patients with spina bifida transitioning from adolescence to adulthood and to guide best care within his or her practice set up.  
  • Recognize the impact of pelvic floor disorders, dysfunctional voiding, and pelvic pain and to return to practice with more developed and multidisciplinary strategies for the best approach to these patients. 
1130-1135    

Introduction

Elise De, United States
Sherif Mourad, Egypt
1135-1155    

Panel—Neurogenic Bladder

   

Global Considerations: Long-Term Follow Up and Underdeveloped Countries

Giovanni Mosiello, Italy
   

Transitional Urological Management of Adolescents with Spina Bifida

Yasuhiko Igawa, Japan
1155-1225    

State of the Art Lectures

   

Dysfunctional Voiding

Gopal Badlani, United States
   

Fistula in 2018: Complex Surgical Management

Sherif Mourad, Egypt
   

Clinical Implications of Underactive Bladder

Kyu-Sung Lee, South Korea
1225-1255    

Roundtable—Pelvic Pain

   

Diagnostic Algorithm

Elise De, United States
   

Non-Medical Approaches to the Treatment of Pelvic Pain

Talli Rosenbaum, Israel
   

Holistic Treatment of Pelvic Pain: Colorectal Perspective

Massarat Zutshi, United States
1255-1300    

Question and Answer

1130-1300

COMP: Complications—This Is How I Manage It: Audience-Submitted Cases    

Room: 5F Baekdu C
Co-Chairs: Anil Mandhani, India / Amlesh Seth, India
Social Media Moderator: Phillip M. Pierorazio, United States

Registered participants will be solicited for case submissions via e-mail in advance of the Congress. The Chair will review submissions and make case selections. Cases will be presented to the audience and discussed/debated with experts.

At the end of this session, the learner will:

  • Apply the knowledge to avoid certain steps in surgery to prevent complications.
  • Recall steps to deal with such untoward incidences if at all they surface during surgery or intervention

 

   

Story after Percutaneous Nephrolithotomy

Mahesh R. Desai, India
   

I Aspirated Bile after an Initial Puncture while Doing PCNL: What Next?

Preetham Dev, India
   

Is Gastric Conduit an Option for Urinary Diversion?

Anthony Mundy, United Kingdom
   

High Drain Output in Kidney Transplant Recipient in Immediate Post Operative Period: What Shall I Do?

Anil Mandhani, India
   

Ghost Bladder: An Enigma!

Sunil B Moteria, India
   

Flank Pain after Laparoscopic Appendectomy

Nagesh Kamat, India
   

IVC Bleeding during Lap Radical Nephrectomy for RCC with IVC Thrombus

Mallikarjuna Chiruvella, India
   

Hem-o-lok Clip Over the Main Renal Artery: What Shall I Do?

Prahara Yuri, Indonesia
   

Rapid-Fire Round

Amlesh Seth, India
   

Expert Panel

John Denstedt, Canada
Dan Wood, United States

1300-1415

Lunch Break  

Room: 5F Baekdu D

1415-1545

IC08: Instructional Course 08—Penile Prosthesis  

Room: 4F Baekje 2/3/4
Chair: Faysal Yafi, United States

At the end of this session, the learner will:

  • Prepare and set up for various techniques of penile prosthesis surgery
  • Perform standard and complex penile prosthesis procedures
  • Evaluate and manage complications related to penile prosthesis surgery
   

Faculty

Lawrence Jenkins, United States
Sung Hun Park, South Korea
Faysal Yafi, United States
   

Topics

   

Overview, work-up and management options for erectile dysfunction

   

Overview of different penile prostheses (malleable, 2- and 3-piece inflatable implants)

   

Patient preparation and positioning for penile prosthesis surgery

   

Different approaches for penile prosthesis placement (penoscrotal, infrapubic, penoscrotal)

   

Minimally invasive penile prosthesis placement under local anesthesia

   

Different approaches for reservoir placement

   

Prosthesis placement in Peyronie’s disease and fibrosis

   

Management of intraoperative complications

   

Management of post-operative complications

   

Mini-Jupette for the management of climacturia

   

Dual artificial urinary sphincter and penile prosthesis placement

   

Follow-up of patients after penile prosthesis placement

1415-1545

MP-11: Moderated ePoster Session 11—Voiding Dysfunction  

Room: 5F Goguryeo 1
Moderators: Joon Chul Kim, South Korea / Karl-Dietrich Sievert, Germany

To view a list of scheduled presentations for this session, please click here

1415-1545

MP-12: Moderated ePoster Session 12—Kidney & Ureteral Cancer  

Room: 5F Goguryeo 2
Moderators: Woong Kyu Han, South Korea / Athanasios (Thanos) Papatsoris, Greece

To view a list of scheduled presentations for this session, please click here

1415-1545

MP-13: Moderated ePoster Session 13—Reconstruction and Trauma  

Room: 5F Goguryeo 3
Moderators: Kurt McCammon, United States / Hong Seok Park, South Korea

To view a list of scheduled presentations for this session, please click here

1415-1735

RF: Residents' Forum: Moderated ePoster Session  

Room: 4F Baekje 6
Moderators: Sang Don Lee, South Korea / Imogen Patterson, Australia

To view the list of scheduled presentations, please click here.

1415-1545

IC09: Instructional Course 09—Neoadjuvant Therapy as the Foundation for Immunotherapy Advances in Muscle-Invasive Urothelial Bladder Carcinoma (MIUBC)  

Room: 3F Shilla 4
Chair: Andrea Necchi, Italy

At the end of this session, the learner will:

  • Understand and apply the criteria for patient inclusion in neoadjuvant trials of ICI (i.e., to include cisplatin-ineligible patients only or all comers).
  • Discuss what is the optimal number of immunotherapy administrations, optimal methods to stage patients and evaluate clinical response to immunotherapy in bladder tumors, toxicity and side effects exposure prior to radical cystectomy, role of maintenance therapy after surgery
  • Discuss the translational findings that the neoadjuvant therapy model may generate in muscle-invasive bladder cancer
  • Know which are the ongoing trials in the neoadjuvant and adjuvant setting of bladder cancer and delineate the pathways of clinical research in the field of urothelial bladder carcinoma
1415-1435    

The Landscape of Clinical Trials in Early-Stage MIUBC

Jens Bedke, Germany
1435-1455    

Translating Clinical Findings to Scientific Advances: The Neoadjuvant Paradigm in MIBC

1455-1515    

Challenges in Developing Immunotherapy Trials in MIBC: Lessons Learned from an Ongoing Trial

Andrea Necchi, Italy
1515-1545    

Clinical Case Discussions

Discussants
Jens Bedke, Germany
Andrea Necchi, Italy

1415-1545

CONT04: Controversies in Urology 4—MR/US Fusion Prostate Biopsy: Best Approach    

Room: 5F Baekdu C
Chair: John Davis, United States
Social Media Moderator: Jeremy Grummet, Australia

At the end of this session, the learner will:

  • Compare the relative strengths and limitations of transrectal versus transperineal fusion biopsy systems
  • Recognize patient level impact from specialty biopsies
  • Recall options for patients with clinical risk of cancer but no clear targets on MRI imaging
1415-1425    

Introduction— High Impact Decisions in Specialty Prostate Biopsies

John Davis, United States
1425-1440    

Transperineal Approach

Sunao Shoji, Japan
1440-1455    

Transrectal Approach

Robert Reiter, United States
1455-1510    

In-Bore MR-Guided Approach

Lance Hampton, United States
1510-1525    

What To Do If There Is No Clear Target

Jeremy Grummet, Australia
1525-1545    

Cases and Discussion

Discussants
John Davis, United States
Jeremy Grummet, Australia
Lance Hampton, United States
Robert Reiter, United States
Sunao Shoji, Japan

1415-1735

SMV03: Surgical Masters Videos 3—Female Urology  

Room: 5F Baekdu A+B
Co-Chairs: John Heesakkers, The Netherlands / Vincent Tse, Australia

At the end of this session, the learner will:

  • Recognize the various surgical approaches to the female urethra and how they are applied
  • Consider when to use vaginal flap techniques and grafts such as buccal mucosa and fascial sling in urethral reconstruction
  • Comprehend the challenges involved in transvaginal mesh removal and when to perform full versus partial removal
  • Identify factors associated with successful vesicovaginal fistula repair
  • Discuss continent urinary diversion solutions
1415-1430    

Dorsal Onlay Technique of Female Urethroplasty

Arabind Panda, India
1430-1445    

Endoscopic Attempts at Mesh Removal

Gopal Badlani, United States
1445-1500    

Closure of a Vesico-Vaginal Fistula

John Heesakkers, The Netherlands
1500-1515    

Huge VVF via Vaginal Route

Ajit Vaze, India
1515-1530    

Stage III and IV Cystocele Repair Supported by Fascial Sling

Janice Cheng, Australia
1530-1545    

Female Urethral Stricture-Review and Transurethral Technique to Minimize Morbidity

Justin Chee, Australia
1545-1600    

Dorsal Approach to Multilobar Urethral Diverticulum Repair

Vincent Tse, Australia
1600-1615    

Continent Urinary Diversion

Sherif Mourad, Egypt
1615-1630    

Open Implantation of an Artificial Sphincter in a Female

Karl-Dietrich Sievert, Germany
1630-1735    

Discussion

1545-1605

Break  

Room: 5F Baekdu D

1605-1735

IC10: Instructional Course 10—Urethroplasty: What to Do and How to Do It  

Room: 4F Baekje 2/3/4
Chair: Francisco E. Martins, Portugal

At the end of this session, the learner will:

  • Determine criteria for selection of the most appropriate technique for urethral reconstruction based on location and etiology of the stricture
  • Determine the best onlay graft urethroplasty for each individual situation
  • Select the best therapeutic approach for complex and reoperative cases, such as single-stage or staged reconstruction
  • Define the resources available for each individual stricture 
1605-1607    

Introduction and Overview

Francisco E. Martins, Portugal
1607-1632    

Ventral Buccal Mucosa Graft (BMG) Urethroplasty for Short Strictures and Dorsal BMG Urethroplasty for Long Strictures

Francisco E. Martins, Portugal
1632-1657    

Anastomotic Urethroplasty for Pelvic Fracture Urethral Injury (PFUI) and AUA Stricture Guidelines: What You Need to Know

Sanjay Kulkarni, India
1657-1722    

Two-Stage Urethroplasty for Post-Hypospadias Repair Strictures and Redo Urethroplasty: What to Do

Matthias Hofer, United States
1722-1735    

Discussion and Polling

Francisco E. Martins, Portugal

1605-1735

MP-14: Moderated ePoster Session 14—UTUC and Miscellaneous  

Room: 5F Goguryeo 1
Moderators: Jens Bedke, Germany / Byong Chang Jeong, South Korea

To view a list of scheduled presentations for this session, please click here

1605-1735

MP-15: Moderated ePoster Session 15—Prostate Cancer  

Room: 5F Goguryeo 2
Speaker: Nianzeng Xing, China
Moderator: Dongdeuk Kwon, South Korea

To view a list of scheduled presentations for this session, please click here

1605-1735

MP-16: Moderated ePoster Session 16—PNL, Training and Transplants  

Room: 5F Goguryeo 3
Moderators: Bum Soo Kim, South Korea / André van der Merwe, South Africa

To view a list of scheduled presentations for this session, please click here

1605-1735

IC11: Instructional Course 11—Work-up and Management of Prostate Cancer Following Local Radiation Failure  

Room: 3F Shilla 4
Chair: Joseph Chin, Canada

At the end of this session, the learner will:

  • Identify potentially curative local salvage possibilities following radiation failure and be able to diagnosis local versus extra-pelvic recurrence following radiotherapy, using established (i.e. mpMRI) and emerging (e.g. PSMA PET) imaging techniques.
  • Formulate best treatment options for patients with recurrence after prostate radiotherapy, and to triage accordingly, being mindful of side effect profiles, indications and contraindications of different local salvage modalities.
  • Recognize the nuances regarding the technical aspects of salvage radical prostatectomy and the various minimally invasive therapies, for safe and efficient execution in the properly selected patients.
  • Be familiar with the outcomes and adverse effects of various salvage treatment modalities.
1605-1610    

Introduction and General Overview

Joseph Chin, Canada
1610-1625    

Work-up • Local versus Distant Failure • PSA Kinetics • Imaging (emerging: PSMA PET, established: multiparametric MRI,)

Glenn Bauman, Canada
1625-1725    

Salvage Options for Localized Failures

   

Salvage Prostatectomy/Salvage Cystoprostatectomy

Yves Fradet, Canada
   

Minimally Invasive Salvage Whole-Gland Ablative Procedures (Salvage Cryoablation/HIFU/ Interstitial Laser plus others

Joseph Chin, Canada
   

Focal Salvage Ablation

Joseph Chin, Canada
   

Brachytherapy for EBRT Failure

Glenn Bauman, Canada
1725-1728    

Summation

Joseph Chin, Canada
Yves Fradet, Canada
1728-1735    

Questions and Discussion

Joseph Chin, Canada

1605-1735

CONT05: Controversies in Urology 5—Renal Cancer: Management of Small Renal Masses in Elderly Patients  

Room: 5F Baekdu C
Chair: Pilar Laguna, Türkiye

At the end of this session, the attendee will be able to:

  • Compare outcomes among the possible treatments of SRM in the Elderly
  • Summarize recent data available, including prevalence of RCC among SRMs
  • Analyze the outcomes and impact of HRQOL of different treatment options
  • State the current indications and factors that can balance the choice of the treatment
1605-0000    

Introduction and Case Illustrations

Pilar Laguna, Türkiye
1615-1635    

Active Surveillance

Phillip M. Pierorazio, United States
1635-1655    

Ablation

Seok Ho Kang, South Korea
1705-1725    

Nephron-Saving Strategy

Nobuyuki Hinata, Japan